Actionable news
0
All posts from Actionable news
Actionable news in NVAX: Novavax, Inc.,

Novavax (NVAX) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Novavax ( NVAX) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Novavax as such a stock due to the following factors:

  • NVAX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $40.3 million.
  • NVAX has traded 452,145 shares today.
  • NVAX is down 3.3% today.
  • NVAX was up 13.8% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in NVAX with the Ticky from Trade-Ideas. See the FREE profile for NVAX NOW at Trade-Ideas More details on NVAX: Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Currently there are 6 analysts that rate Novavax a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Novavax has been 6.7 million shares per day over the past 30 days. Novavax...


More